The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure
Abstract
BACKGROUND: It is common practice to restore and maintain sinus rhythm in patients with atrial fibrillation and heart failure. This approach is based in part on data indicating that atrial fibrillation is a predictor of death in patients with heart failure and suggesting that the suppression of atrial fibrillation may favorably affect the outcome. However, the benefits and risks of this approach have not been adequately studied. METHODS: We conducted a multicenter, randomized trial comparing the maintenance of sinus rhythm (rhythm control) with control of the ventricular rate (rate control) in patients with a left ventricular ejection fraction of 35% or less, symptoms of congestive heart failure, and a history of atrial fibrillation. The primary outcome was the time to death from cardiovascular causes. RESULTS: A total of 1376 patients were enrolled (682 in the rhythm-control group and 694 in the rate-control group) and were followed for a mean of 37 months. Of these patients, 182 (27%) in the rhythm-control group died from cardiovascular causes, as compared with 175 (25%) in the rate-control group (hazard ratio in the rhythm-control group, 1.06; 95% confidence interval, 0.86 to 1.30; P=0.59 by the log-rank test). Secondary outcomes were similar in the two groups, including death from any cause (32% in the rhythm-control group and 33% in the rate-control group), stroke (3% and 4%, respectively), worsening heart failure (28% and 31%), and the composite of death from cardiovascular causes, stroke, or worsening heart failure (43% and 46%). There were also no significant differences favoring either strategy in any predefined subgroup. CONCLUSIONS: In patients with atrial fibrillation and congestive heart failure, a routine strategy of rhythm control does not reduce the rate of death from cardiovascular causes, as compared with a rate-control strategy. (ClinicalTrials.gov number, NCT00597077.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Antiarrhythmic drugs approximately double the rate of sinus rhythm compared with placebo.[580][581][582][583][584]”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [582]
Citations
Cites
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043399 · Cited by 6,552
Effects of Enalapril on Mortality in Severe Congestive Heart Failure
The Consensus Trial Study Group* (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162301 · Cited by 5,109
Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575
A comparison of rate control and rhythm control in patients with atrial fibrillation
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa021328 · Cited by 4,405
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805
Self-citationGelder, I. C. V., Hagens, V. E., Bosker, H. A., Kingma, J. H., Otto Kamp, B., Kingma, T., Said, S. A., Darmanata, J. I., Timmermans, A. J. M., Tijssen, J. G. P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021375 · Cited by 2,355
Feinberg, W. M. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.5.469 · Cited by 2,282
Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., CHAITMAN, B. R., FROMER, M. A., Gregoratos, G., Klein, G. J., Myerburg, R. J., Quiñones, M. A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.010 · Cited by 1,975
Wang, T. J., Larson, M. G., Levy, D., Vasan, R. S., Leip, E. P., Wolf, P. A., D’Agostino, R. B., Murabito, J. M., Kannel, W. B., & Benjamin, E. J. (2003) · Circulation · doi:10.1161/01.cir.0000072767.89944.6e · Cited by 1,970
Cardiovascular Medicine at the Turn of the Millennium: Triumphs, Concerns, and Opportunities
Braunwald, E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711063371906 · Cited by 1,426
Hohnloser, S. H., Kück, K., & Lilienthal, J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03230-x · Cited by 1,132
Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy
Maisel, W. H., & Stevenson, L. W. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)03373-8 · Cited by 972
Dries, D. L., Exner, D., Gersh, B., DOMANSKI, M. J., Waclawiw, M. A., & Stevenson, L. W. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00297-6 · Cited by 967
Coplen, S. E., Antman, E. M., Berlin, J. A., Hewitt, P., & Chalmers, T. C. (1990) · Circulation · doi:10.1161/01.cir.82.4.1106 · Cited by 946
Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation
CARLSSON, J., Miketíc, S., Windeler, J., Cuneo, A., Haun, S., Micus, S., Walter, S., & Tebbe, U. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00332-2 · Cited by 938
Heart failure with preserved left ventricular systolic function
Hogg, K. J., Swedberg, K. B., & McMurray, J. J. V. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.07.046 · Cited by 927
Randomised trial of low-dose amiodarone in severe congestive heart failure
Doval, H., Nul, D. R., Grancelli, H., Perrone, S. V., Bortman, G., & Curiel, R. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91895-3 · Cited by 913
Catheter Ablation for Atrial Fibrillation in Congestive Heart Failure
Hsu, L., Jaı̈s, P., Sanders, P., Garrigue, S., Hocini, M., Sacher, F., Takahashi, Y., Rotter, M., Pasquié, J., Scavée, C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041018 · Cited by 890
Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation
Flaker, G. C., Blackshear, J. L., McBride, R., Kronmal, R. A., Halperin, J. L., & Hart, R. G. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90003-6 · Cited by 633
Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients.
Middlekauff, H. R., Stevenson, W. G., & Stevenson, L. W. (1991) · Circulation · doi:10.1161/01.cir.84.1.40 · Cited by 576
Olsson, L. G., Swedberg, K., Ducharme, A., Granger, C. B., Michelson, E. L., McMurray, J. J. V., Puu, M., Yusuf, S., & Pfeffer, M. A. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.01.060 · Cited by 574
DEEDWANIA, P. C., Singh, B. N., Ellenbogen, K. A., Fisher, S. G., Fletcher, R. D., & Singh, S. N. (1998) · Circulation · doi:10.1161/01.cir.98.23.2574 · Cited by 505
Rate Control vs Rhythm Control in Patients With Nonvalvular Persistent Atrial Fibrillation
Opolski, G., Torbicki, A., KOSIOR, D. A., Szulc, M., Wożakowska−Kapłon, B., Kołodziej, P., & Achremczyk, P. (2004) · CHEST Journal · doi:10.1378/chest.126.2.476 · Cited by 473
Medical Management of Advanced Heart Failure
Nohria, A. (2002) · JAMA · doi:10.1001/jama.287.5.628 · Cited by 466
Natural history and patterns of current practice in heart failure
Bourassa, M. G., Gurné, O., Bangdiwala, S. I., Ghali, J. K., Young, J. B., Rousseau, M. F., Johnstone, D. E., & Yusuf, S. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90456-b · Cited by 360
Carson, P. E., Johnson, G. R., Dunkman, W. B., Fletcher, R. D., Farrell, L., & Cohn, J. N. (1993) · PubMed · Cited by 319
Improving survival for patients with atrial fibrillation and advanced heart failure
Stevenson, W. G., Stevenson, L. W., Middlekauff, H. R., Fonarow, G. C., Hamilton, M. A., Woo, M. A., Saxon, L. A., Natterson, P. D., Steimle, A. E., Walden, J. A., et al. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00358-0 · Cited by 218
Lehto, M. (2004) · European Heart Journal · doi:10.1093/eurheartj/ehi064 · Cited by 195
Ehrlich, J. R., Nattel, S., & Hohnloser, S. H. (2002) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2002.00399.x · Cited by 189
Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., CHAITMAN, B. R., FROMER, M. A., Gregoratos, G., Klein, G. J., Myerburg, R. J., Quiñones, M. A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.008 · Cited by 184
Carson, P. E., Johnson, G. R., Dunkman, W. B., Fletcher, R. D., Farrell, L., & Cohn, J. N. (1993) · Circulation · Cited by 157
The AF-CHF Trial Investigators (2002) · American Heart Journal · doi:10.1016/s0002-8703(02)00129-1 · Cited by 148
Mathew, J., Hunsberger, S., Fleg, J. L., Sherry, F. M., Williford, W. O., & Yusuf, S. (2000) · CHEST Journal · doi:10.1378/chest.118.4.914 · Cited by 139
Stulak, J. M., Dearani, J. A., Daly, R. C., Zehr, K. J., Sundt, T. M., & Schaff, H. V. (2006) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2006.03.075 · Cited by 86
Brignole, M. (2002) · European Heart Journal · doi:10.1053/euhj.2001.2971 · Cited by 80
Improving Outcomes in Heart Failure
Moser, D. K., & Mann, D. L. (2002) · Circulation · doi:10.1161/01.cir.0000021745.45349.bb · Cited by 71
Zaręba, W., Steinberg, J. S., McNitt, S. A., Daubert, J. P., Piotrowicz, K., & Moss, A. J. (2006) · Heart Rhythm · doi:10.1016/j.hrthm.2006.02.012 · Cited by 58
Atrial Fibrillation in Heart Failure:
Naccarelli, G. V., Hynes, B. J., Wolbrette, D. L., Bhatta, L., Khan, M. R., Samii, S. M., & Luck, J. C. (2003) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2003.90404.x · Cited by 49
Grönefeld, G., & Hohnloser, S. H. (2003) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/107424840300800203 · Cited by 35
Rhythm versus Rate Control Trials in Atrial Fibrillation
Wyse, D. G. (2003) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.14.s9.17.x · Cited by 29
Atrial fibrillation in patients with heart failure
Hynes, B. J., Luck, J. C., Wolbrette, D. L., Bhatta, L., Khan, M. R., Samii, S. M., & Naccarelli, G. V. (2003) · Current Opinion in Cardiology · doi:10.1097/00001573-200301000-00005 · Cited by 24
Flagged first, then by citations
Research works printed but not linked: 1
- Carson PE, 1993, Circulation, 87, VI
Cited by
Sorted by citations
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2021) · PubMed · doi:10.1093/eurheartj/ehab670 · Cited by 20,604
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Self-citation2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H. G., Cigarroa, J. E., Cleveland, J. C., CONTI, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,145
Metadata
- Authors
- Roy, D., Talajic, M., Nattel, S., Wyse, D. G., Dorian, P., Lee, K. L., Bourassa, M. G., Arnold, J. M. O., Buxton, A. E., Camm, A. J., Connolly, S. J., Dubuc, M., Ducharme, A., Guerra, P. G., Hohnloser, S. H., Lambert, J., Le Heuzey, J.-Y., O'Hara, G., Pedersen, O. D., Rouleau, J.-L., Singh, B. N., Stevenson, L. W., Stevenson, W. G., Thibault, B., & Waldo, A. L.
- Affiliations
- Montreal Heart Institute (CA)
- Libin Cardiovascular Institute of Alberta (CA)
- St. Michael's Hospital (CA)
- Duke Medical Center (US)
- London Health Sciences Centre (CA)
- Rhode Island Hospital (US)
- St George's Hospital (GB)
- Population Health Research Institute (CA)
- Goethe University Frankfurt (DE)
- Bispebjerg Hospital (DK)
- VA West Los Angeles Medical Center (US)
- Brigham and Women's Hospital (US)
- University Hospitals Cleveland Medical Center (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-06-19
- Volume
- 358
- Issue
- 25
- Pages
- 2667-2677
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2131260805
- Cited by
- 1,585
- References
- 41
- Citations by year
- 2026: 42 · 2025: 33 · 2024: 69 · 2023: 55 · 2022: 76 · 2021: 86 · 2020: 77 · 2019: 82 · 2018: 96 · 2017: 87 · 2016: 73 · 2015: 75 · 2014: 87 · 2013: 123 · 2012: 114
- FWCI
- 97.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Keywords
- atrial fibrillation, heart failure, rhythm control, rate control, sinus rhythm maintenance, ventricular rate control, cardiovascular mortality, congestive heart failure, stroke, worsening heart failure, left ventricular ejection fraction
- MeSH terms
- Adrenergic beta-Antagonists, Aged, Amiodarone, Angiotensin-Converting Enzyme Inhibitors, Anti-Arrhythmia Agents, Atrial Fibrillation, Cardiovascular Diseases, Combined Modality Therapy, Digitalis Glycosides, Electric Countershock, Female, Follow-Up Studies, Heart Failure, Heart Rate, Hospitalization, Humans, Male, Middle Aged, Prospective Studies, Ventricular Dysfunction, Left, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review